Compare MIST & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIST | HYMC |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Canada | United States |
| Employees | N/A | 51 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 3.4B |
| IPO Year | 2019 | N/A |
| Metric | MIST | HYMC |
|---|---|---|
| Price | $1.41 | $32.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 1.3M | ★ 2.0M |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $2.95 |
| 52 Week High | $3.06 | $58.73 |
| Indicator | MIST | HYMC |
|---|---|---|
| Relative Strength Index (RSI) | 32.88 | 41.66 |
| Support Level | $1.00 | $31.31 |
| Resistance Level | $2.30 | $46.05 |
| Average True Range (ATR) | 0.12 | 3.02 |
| MACD | -0.05 | -0.80 |
| Stochastic Oscillator | 0.81 | 12.13 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Hycroft Mining Holding Corp is a United States-based gold and silver exploration-stage issuer. The company owns and is focused on developing its property, the Hycroft Mine, located northwest of Winnemucca, Nevada.